Goat Anti-Mouse IgG (H+L) FITC -conjugated - #S0007
| Product: | Goat Anti-Mouse IgG (H+L) FITC -conjugated |
| Catalog: | S0007 |
| Source: | Goat |
| Application: | WB, IF/ICC, FACS |
| Reactivity: | Mouse |
| RRID: | AB_2843438 |
Product Info
Source:
Goat
Application:
WB 1:100 – 1:500, IF/ICC 1:100 – 1:500
*The optimal dilutions should be determined by the end user.
*The optimal dilutions should be determined by the end user.
Reactivity:
Mouse
Clonality:
Polyclonal
RRID:
AB_2843438
Cite Format: Affinity Biosciences Cat# S0007, RRID:AB_2843438.
Cite Format: Affinity Biosciences Cat# S0007, RRID:AB_2843438.
Conjugate:
FITC. Ex:495nm/Em:520nm
Purification:
affinity purification.
Concentration:
1mg/ml
Storage:
0.01M Sodium phosphate, 0.25M NaCl, 50% glycerol, pH7.6.Store at -20℃，avoid repeated thawing and freezing.
Immunogens
Immunogen:
The antiserum was developed in goat using the MOUSE IgG as the immunogen.
References
1). Zhang L et al. Chemerin-Induced Down-Regulation of Placenta-Derived Exosomal miR-140-3p and miR-574-3p Promotes Umbilical Vein Endothelial Cells Proliferation, Migration, and Tube Formation in Gestational Diabetes Mellitus. Cells 2022 Nov 1;11(21):3457. (PubMed: 36359855)
[IF=6.600]
2). Jiang Y et al. Hedgehog pathway inhibition causes primary follicle atresia and decreases female germline stem cell proliferation capacity or stemness. Stem Cell Res Ther 2019 Jul 5;10(1):198 (PubMed: 31277696)
[IF=5.116]
3). Zhou H et al. Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. Biol Trace Elem Res 2019 Aug;190(2):327-335 (PubMed: 30421162)
[IF=4.081]
4). Liu Q et al. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells. Acta Biochim Biophys Sin (Shanghai) 2019 Jul 10;51(7):707-714 (PubMed: 31187140)
[IF=3.511]
5). Dong S et al. Carbenoxolone has the potential to ameliorate acute incision pain in rats. Mol Med Rep 2021 Jul;24(1):520. (PubMed: 34013377)
[IF=3.423]
6). Study on β-Chitosan against the binding of SARS-CoV-2S-RBD/ACE2.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.